In order to determine if our purR final construct would successfully produce mScarlet protein in response to guanine concentration, we transformed the construct into competent E. coli cells and inoculated different types of media with 3 isolates of the purR final construct.
Our purR construct produces the mScarlet reporter protein in LB media but not in M9 media or M9 media supplemented with guanine. This could mean a few things:
Before completely re-designing the purR construct, we need to carry out further testing to determine what is wrong with the first iteration.
In order to determine if our Guanine-II Riboswitch final construct would successfully produce mScarlet protein in response to guanine concentration, we transformed the construct into competent E. coli and inoculated different types of media with 3 isolates of the purR final construct. Each isolate was inoculated into LB, LB+1nM guanine, M9, and M9+1nM guanine. Additionally, all of the M9 media included 1% thiamine as DH5-alpha is auxotrophic for thiamine.
The riboswitch seems to be completely or near completely non-functional. The constitutive promoter is producing the mScarlet protein regardless of the media type or guanine concentration in the media.
Re-design the SynRiboswitch_BC part. Instead of trying to conserve the sequence listed in the publication, just use the natural and uninterrupted sequence in the genome of the Paenibacillus Sp. HW567. It may not be exactly as listed in the publication, but there may be an error in the publication. The actual sequence taken from the genome should be functional. They studied that strain after all. In other words, align the sequence from the publication to the Paenibacillus Sp. HW567 genome and find the closest match. Take that sequence up until the first stop codon encountered after the aligned region and add BsaI Golden Gate sites to give it _BC overhangs. Another approach would involve looking further into the literature to find any other examples of guanine sensing riboswitches and attempting the same with them.
The two sections above are the primary components we tested. In addition to this, we conducted supplementary experiments and have plans for other future experiments that would improve our understanding of the hive environment. These experiments include quantifying guanine in the hive to find background guanine content as well as understand how much varroa mite infestation will increase guanine concentration by. This will allow us to fine tune our testing process to create pigment at specific guanine concentrations, rather than giving false positives due to background guanine.
Accompany USDA field manager as they counted varroa mite counts using non-lethal powdered sugar test at the beginning and near the end of the season.
Hive # | # Mites (June 27) | # Mites (August 2) |
---|---|---|
3 | 0 | 1 |
6 | 0 | 1 |
11 | 0 | 1 |
12 | 0 | 5 |
One cup is approximately 100 bees, and mite levels should be kept below 1 mite/100 in spring and 2 mites/100 bees for the rest of the year. (University of Minnesota)
The results from sampling the bees at two different time points shows how the amount of varroa mites increased from 0 mites early in the year (6/27) to an average of 2 mites for every 100 bees later in the year (8/2). This testing method may not be completely accurate, due to the proximity of these hives to each other and the tendency for hives close to each other to have similar levels of varroa mite infection (M.A. Stevenson, et al). The potential inaccuracy of this test is part of why there is a need for a new testing method to be developed.
Now that an infected population has been established, next step experiments would involve using these hives to determine guanine concentration in the hive based on varroa mite infestation level. This would involve continuing to monitor the varroa mite infection within the hive. Brood cells would then be swabbed to as samples for high performance liquid chromatography to determine guanine levels in the hive. Once guanine concentration was found for specific levels of infection we could fine tune the production of mScarlet to only be created at levels of guanine indicating a varroa mite infection. This would prevent false positives by calibrating our design to only start production under correct conditions.
We conducted experiments to understand the guanine sensing capabilities of our new part, and supplementary experiments to understand the parameters of our environmental conditions. The majority of our experiments were unsuccessful, but they gave us useful insight on how we can improve our design. Using these results, we know what changes to make to our designs and experimental processes. On top of this, there are multiple other experiments that would be conducted to fine tune and finalize our designs.